Experience

yes.we.health
• Brazil
• Advertising Services
• 1 - 100 Employee
• Founder

  • Sep 2022 - Present

FIA - Labfin Provar
• Brazil
• Higher Education
• 1 - 100 Employee
• Professor MBA - Gestão de Marketing Farmacêutico

  • Aug 2022 - Present


moksha8 Pharmaceuticals, Inc

• Marketing, Market Intelligence and Field Force Director

  • Feb 2016 - Dec 2021

  Leadership of strategic new thinking, to turn the company profitable through portfolio evaluation, products repositioning and field force resizing. Participation in new business projects, scouting and analyzing new products using financial and analytics approaches. Strong focus on compliance and partners contract management. Creation of a new, online hybrid strategy for medical promotion. Development of a successful concept of service reps to work with low margin products. Implementation of a comprehensive forecast platform, considering sell in, sell out, inventory and market trends. Intense use of analytics to understand geographic areas and its sales potential. Show less



Marketing and Sales Consultant

• Manufacturing
• 1 - 100 Employee

• Marketing | Healthcare | Sales Force | Market Research | Sales

  • Jul 2014 - Apr 2015

  Consultancy Projects, focusing on multichannel tool platforms and digital promotion. Main client was Tabmedia, managing projects with local and global companies focusing on Field Force performance analytics. Six new contracts were signed (+20% in sales). Consultancy Projects, focusing on multichannel tool platforms and digital promotion. Main client was Tabmedia, managing projects with local and global companies focusing on Field Force performance analytics. Six new contracts were signed (+20% in sales).



Shire Pharmaceuticals

• Senior Product Manager - Rare diseases

  • Feb 2013 - Jun 2013

  In charge of Elaprase, main product of the company (USD 150 million), indicated to treat MPS II (Rare Disease). Creation and management of a new analytics strategy to find new patients in Brazil, using population data (IBGE), increasing from 250 to 280 patients in 4 months. Reason for leaving the company: Moving to USA In charge of Elaprase, main product of the company (USD 150 million), indicated to treat MPS II (Rare Disease). Creation and management of a new analytics strategy to find new patients in Brazil, using population data (IBGE), increasing from 250 to 280 patients in 4 months. Reason for leaving the company: Moving to USA



Ipsos

• France
• Market Research
• 700 & Above Employee

• Account Director | Marketing | Healthcare

  • Sep 2011 - Feb 2013

  Head da área de Healthcare, responsável pelo P&L. Recuperação da imagem de qualidade da empresa através da reestruturação total da equipe, crescendo 70% no primeiro ano e atingindo R$ 12 milhões em vendas de serviços. NPS mais alto entre a divisão Ipsos Healthcare globalmente, atingindo score 91. Desenvolvimento de analytics, desk research, pesquisas qualitativas e quantitativas para empresas como Fleury Laboratórios, Sanofi, Bayer, Eli Lilly, Aché, Daiichi Sankyo, Novartis, MSD e Pfizer. Head da área de Healthcare, responsável pelo P&L. Recuperação da imagem de qualidade da empresa através da reestruturação total da equipe, crescendo 70% no primeiro ano e atingindo R$ 12 milhões em vendas de serviços. NPS mais alto entre a divisão Ipsos Healthcare globalmente, atingindo score 91. Desenvolvimento de analytics, desk research, pesquisas qualitativas e quantitativas para empresas como Fleury Laboratórios, Sanofi, Bayer, Eli Lilly, Aché, Daiichi Sankyo, Novartis, MSD e Pfizer.



Zambon

• Pharmaceutical Manufacturing
• 700 & Above Employee

• Marketing Director, Market Intelligence, Targeting and Field Force Services Director

  • Jan 2008 - Jan 2011

  Development of public hospital strategy for Ursacol, creating a public sales team and growing 30% in units in the first year (product with more than 30 years in Brazilian market). Repositioning of all products in the portfolio, focusing on respiratory (OTC) and gynecology, reaching a CAGR growth of 20% (net sales) in three years. Creation of a new model of forecasting, using weather data analysis to plan winter products campaigns. Development of public hospital strategy for Ursacol, creating a public sales team and growing 30% in units in the first year (product with more than 30 years in Brazilian market). Repositioning of all products in the portfolio, focusing on respiratory (OTC) and gynecology, reaching a CAGR growth of 20% (net sales) in three years. Creation of a new model of forecasting, using weather data analysis to plan winter products campaigns.



AstraZeneca

• United Kingdom
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Product Manager

  • Feb 2006 - Apr 2007

  In charge of product repositioning and launch of new indications (emphysema). Analysis of market environment and product and competitors characteristics. Creation of a specific respiratory field force, Road Show to train representatives about product benefits, main objections and new sales speech. Personal visits to main prescribers in Brazil (100 doctors) to discuss about new indications and benefits of the product and its medical device (turbuhaler, a different kind of Inhaler). Development of qualitative and quantitative surveys to find main barriers to doctors’ prescription, once it was a low performance product. Internal sales increased about 30% in units after 2 years. Show less



Boehringer Ingelheim

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Group Products Manager

  • 2002 - 2006

  Head of Respiratory Line Marketing Franchise, with sales of R$ 250 million in Brazil Spiriva (COPD) product manager, responsible for its launching in Brazil (2003) in partnership with Pfizer, reaching R$ 50 million sales. Head of Respiratory Line Marketing Franchise, with sales of R$ 250 million in Brazil Spiriva (COPD) product manager, responsible for its launching in Brazil (2003) in partnership with Pfizer, reaching R$ 50 million sales.



Pharmacia & Upjohn

• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Senior Product Manager

  • 2001 - 2002

  CURRENT PFIZER - Product management of Celebra, in partnership with Pfizer, reaching R$ 100 million sales in Brazil. CURRENT PFIZER - Product management of Celebra, in partnership with Pfizer, reaching R$ 100 million sales in Brazil.



Novartis

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Marketing Manager

  • 1993 - 2001

  Marketing Manager LATAM for mature products (Biogalênica) Group products manager (Central Nervous System) District Manager (13 representatives) Senior Product Manager (Neurology Line) Product Manager (Neurology and Anxiety Line) Trainning Coordenator (Ciba-Sandoz merger) Representative Marketing Manager LATAM for mature products (Biogalênica) Group products manager (Central Nervous System) District Manager (13 representatives) Senior Product Manager (Neurology Line) Product Manager (Neurology and Anxiety Line) Trainning Coordenator (Ciba-Sandoz merger) Representative



FARMASA S/A - Laboratório Americano de Farmacoterapia

• Brazil
• Pharmaceutical Manufacturing

• Representative

  • 1991 - 1993

  Therapeutic areas: Gastroenterology, Gynaecology, Orthopedics, Pediatrics, Cardiology Therapeutic areas: Gastroenterology, Gynaecology, Orthopedics, Pediatrics, Cardiology



Bristol-Myers Squibb

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Representative

  • 1990 - 1991

  Gastroenterology, Gynaecology, Orthopedics, Pediatrics, Cardiology Gastroenterology, Gynaecology, Orthopedics, Pediatrics, Cardiology



Sanofi

• France
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Representative

  • 1989 - 1990

  Gastroenterology, Gynaecology, Orthopedics, Pediatrics, Cardiology, Urology, Otolaryngology, Alergy Gastroenterology, Gynaecology, Orthopedics, Pediatrics, Cardiology, Urology, Otolaryngology, Alergy